MDS Pharma Services is the latest contract research organisation
(CRO) to branch out into a new and exotic emerging market location,
with the establishment of an office in Sao Paulo, Brazil.
Pharmaceutical Product Development (PPD) has initiated central
laboratory services in China in response to the country's budding
clinical trials scene.
Eli Lilly has released a statement strongly objecting to
implications made in a New York Times article that it has
suppressed results of negative clinical trials.
Outsourcing-Pharma.com compiles the news that featured in the
clinical contract community of late, involving Encorium Group,
Ubichem and Axium Healthcare Pharmacy.
Pharmaceutical Product Development (PPD) and Kendle have been
keeping focused on expanding their global presence, making key
hires to grow their businesses further beyond the US.
Pfizer is vowing to fight on as Nigerian court battles against its
subsidiary in the country wage on over its alleged involvement in
child deaths through experimentation over a decade ago.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving Encorium Group,
Holmes Biopharma and Novotech.
Although India 'has carved out a significant portion of the world
pharma pie', an enormous change in mindset is needed if the country
is to become a global pharmaceutical hub, according to a new report
from KPMG.
One Equity Partners (OEP), the private equity arm of JPMorgan
Chase, is in the process of selling its stake in Quintiles for a
reported sum of over $3bn.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving PPD, PRA, Accutest
and Premier Research.
MDS Pharma is continuing its efforts to move on from the trouble
caused in its Pharma Services segment by a US Food and Drug
Administration (FDA) review of its Montreal-area bioanalytical
facilities.
Two French contract research organisations (CROs) that specialise
in ophthalmology have banded together to offer specialised services
to this niche market.
US researchers have developed a fast and inexpensive protein
biomarker detection device that could simplify disease diagnosis
and aid in following disease progression in drug trials.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving ClinTec, Synexus,
Tripos, Qualia, Icon, and Encorium Group.
Eisai is planning to step up its clinical research presence in Asia
and has chosen Singapore as a hub from which to coordinate its
research activities.
GVK Bio has reinforced its claim to be India's top contract
research organisation with a 100-crore ($25m) push from a private
investment company. The funds will be used to expand its drug
discovery services and push further into...
New research from Frost & Sullivan provides a snapshot of
biopharma spending trends on contract research organisations
(CROs), along with forecasts for industry growth.
While India, the Asia-Pacific, Eastern Europe and Latin America are
all gaining recognition as potential new hot spots, South Africa
remains 'underutilised as a clinical trial destination,'
according to a prominent industry...
Researchers at Randox, UK, have developed a biochip that enables
the simultaneous measurement of 12 human cytokines from human serum
samples enabling cytokine studies to be conducted faster.
Russia's clinical trials industry appears to be making a gradual
recovery from a setback earlier this year when the government
imposed an unexpected ban on biologic exports.
PRA International continues to see its profits ebb away but will
soon face less financial scrutiny as it nears a handover of
ownership into private hands.
BioCryst's recent clinical trials debacle highlights the importance
of the robust and realistic design of, and careful adherence to, a
drug trial protocol.
Management of publicly-traded Synexus have agreed to the £18.1m
(€25.7m) sale of the company to a private equity firm that has
promised to fund its global expansion ventures.
This week two sets of contract research organisations (CROs) have
announced plans to link arms in order to spread their reach further
into this increasingly globalised marketplace.
PharmaNet has made a strong comeback during its third quarter after
previously slipping into the red and recorded its highest revenue
to date - $99.8m (€70.0m).
Icon has improved its financial position significantly during its
third quarter, while its smaller US rival Kendle saw its profit
slip again, weighed down by charges from a 2006 acquisition.
An update to the contract negotiation system for hospital-based
clinical trials has come into play in the UK - in a further effort
to take some of the pain out of the process and speed up trial
start-up times.
Covance is feeling positive after reporting healthy growth in both
business units for the third quarter, with its early phase segment
continuing to have the edge over its late stage unit.
PPD's decision to in-license an investigational compound is proving
to be a drag on its bottom line as the firm continues to seek a
development partner for the drug.
Icon is living up to its name, according to a recent contract
research organisation (CRO) survey, which also recognised Quintiles
and PPD in terms of quality performance.
Two major bioscience industry trade associations have called for
changes to be made to the European clinical trials directive in
order to bring about "harmonisation, transparency and consistency"
in this area across the...
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late involving Clinsys, Averion, PRA
International and others.
Parexel has purchased a clinical research organisation (CRO) in
Taiwan as a means to exert its presence in this industry's budding
Asia-Pacific region.
While contract research organisations (CROs) now dominate the
clinical trials market, questions are being raised about the risks
of 'commercialising' clinical studies, according to new research.
The US Food and Drug Administration (FDA) has been called into
question again after the release of a damning report, this time
suggesting the agency is inadequate in its safety monitoring of
clinical trials.
Pfizer will appear this week in a Nigerian court to face
allegations that it caused the death of Nigerian children over a
decade ago when it conducted a clinical trial of its
meningitis drug Trovan (trovafloxacin) in the country.
This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...
In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...
Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...
